Cheryl R. Blanchard

President and Chief Executive Officer at Anika Therapeutics Inc

Board

Since April 26, 2020

Age

59 years

Education

Earned a Ph.D. and M.S. in Materials Science and Engineering from the University of Texas-Austin and a B.S. in Ceramic Engineering from Alfred University.

Tenure

Joined ANIK as a director in 08-2018 and was promoted to President and Chief Executive Officer on 04-26-2020.

Also at Anika Therapeutics Inc

AMN

Anne M. Nunes

Senior Vice President, Chief Operations Officer

Ian McLeod

Vice President, Chief Accounting Officer

Stephen Griffin

Executive Vice President, Chief Financial Officer, and Treasurer

About

Dr. Cheryl R. Blanchard is a seasoned executive with a robust technical background and a comprehensive career spanning leadership roles in both scientific and corporate environments. She is 59 years old as of the latest data and earned advanced degrees in Materials Science and Engineering along with a B.S. in Ceramic Engineering, positioning her as an expert in her field.

Before joining ANIK, she held several pivotal roles including serving as the President and CEO at Microchips Biotech, Inc. and leading Blanchard Consulting, LLC. Her experience also includes key positions at Zimmer, Inc., where she contributed to advancing research and development initiatives in the medical device industry.

At ANIK, she began her involvement as a director in 08-2018 and was elevated to her current role as President and Chief Executive Officer on 04-26-2020. In this capacity, she has been steering the company through strategic growth and governance advancements, while also holding board positions at other public companies, further reinforcing her commitment to corporate excellence.

$ANIK Performance Under Cheryl R. Blanchard

Past Roles

Organization	Role	Date Range	Details
Daré Bioscience, Inc.	Board Member	November 2019 – June 2024	Ended board service in June 2024
Anika Therapeutics	Interim Chief Executive Officer	February 2020 – April 2020	Served as interim CEO before promotion to President & CEO
Blanchard Consulting, LLC	Principal	2012 – 2020	Provided scientific, regulatory, and business strategy consulting services
Microchips Biotech, Inc.	President & Chief Executive Officer	2014 – November 2019	Led a venture-backed biotechnology company developing regenerative medicine and drug delivery products; company sold to Daré Bioscience
Zimmer, Inc.	Senior Vice President, Chief Scientific Officer, and General Manager of Zimmer Biologics	2000 – 2012	Held various leadership positions in a medical device company focused on musculoskeletal products

External Roles

Organization	Role	Date Range	Details
Vigil Neuroscience, Inc. (NASDAQ: VIGL)	Board Member	Since December 2020	Active board membership

Fixed Compensation

Data from FY 2023

Component Name	Amount	Payment Schedule	Additional Details
Salary	$726,000	Annual	Base salary for 2023
Stock Awards	$1,614,708	Vests over three years commencing on the first anniversary of the grant date	60,004 shares granted on March 9, 2023
Option Awards	$1,509,736	Vests over three years commencing on the first anniversary of the grant date	130,998 securities with an exercise price of $29.60 per share
All Other Compensation	$26,196	Annual	Includes matching 401(k) contributions ($23,100) and group term life insurance premiums

Performance Compensation

Data from FY 2023

Bonus Compensation

Metric	Value
Bonus Target	$617,100
Actual Bonus Paid	$583,160
Achievement	94.5%
Evaluation Period	2023 (Annual)
Performance Metrics	Not provided
Threshold / Cap / Weights	Not provided

Additional Note: The documents indicate that the annual cash bonus was designed to reward both business and individual performance; however, detailed performance metrics, thresholds, caps, weights, and conditions were not provided for 2023.